On October 31,‍ JPMorgan low‍ered its price target on GSK plc (NYSE:GSK) to 1,440 GBp fro⁠m 1,550 GBp w⁠hile maintaining an ...

Trevi Therapeutics is developing nalbuphine ER (Haduvio) for chronic cough in IPF and RCC, targeting unmet medical needs.

A strong performer already, GSK stock is trading up 44% in 2025, yet its stock remains a good bargain. GSK trades for a ...

GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has announced the repurchase of 167,000 of its own shares as part of its ongoing ...

GSK plc (NYSE: GSK) is one of the best undervalued stocks to buy under $50. Deutsche Bank analyst Emmanuel Papadakis released ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GlaxoSmithKline (GSK) has announced a recent purchase of 170,000 of its own ordinary shares ...

GSK PLC's (NYSE: GSK) short interest as a percent of float has risen 6.45% since its last report. According to exchange reported data, there are now 13.33 million shares sold short, which is 0.66% of ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII ...

Learn more about whether BioMarin Pharmaceutical Inc. or Amicus Therapeutics, Inc. is a better investment based on AAII's A+ ...

India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for ...

SCYNEXIS to receive one-time payments totalling $24.8 million from GSK as part of the resolution of the disagreement related to the restart of ...

It pays a semiannual dividend and yields 4.4% based on the two most recent payments. Morningstar Equity analysts note that ...